{
  "docId": "019de071-94a0-75ef-b86b-e4894fa7dc1d",
  "docSlug": "8b4d61768a47893d5f24ee0f1f9ae717",
  "documentTitle": "argenx SE | Results Presentation Deck | 20 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 13,
  "pageCount": 20,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-94a0-75ef-b86b-e4894fa7dc1d/13",
  "deckHref": "/decks/019de071-94a0-75ef-b86b-e4894fa7dc1d",
  "deckJsonHref": "/decks/019de071-94a0-75ef-b86b-e4894fa7dc1d.json",
  "deckAnchorHref": "/decks/019de071-94a0-75ef-b86b-e4894fa7dc1d#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.05,
        "y": 0.45
      },
      "kind": "list",
      "text": "Consistent PK/PD profile across IV and SC dosing that may enable infrequent dosing",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "275cf8a6-ebd1-4da9-99a4-4dcf05604a94",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.05,
        "y": 0.6
      },
      "kind": "list",
      "text": "Phase 2 trial in multifocal motor neuropathy (MMN) to start by end of year",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "71e331c1-ec26-4271-94c4-791f5d10344c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.05,
        "y": 0.3
      },
      "kind": "list",
      "text": "Favorable safety & tolerability profile supports advancing to Phase 2 patient trials",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d6809d08-ffbe-4c30-b877-eb6c830dbcaa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Phase 1 Data Support Path Forward and Potential for Individualized Dosing Schedule in Patients",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aa07e0db-30af-48a2-b9d5-c2e8496c2326",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 13,
      "from": 11,
      "beatId": "4f8f83fb-eef9-4722-9631-243f8b42a5e3",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "New Bliss",
      "beatSlug": "sparkline-new-bliss",
      "evidence": "The thesis headline and propose solution slides present the potential for individualized dosing schedules",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 13,
      "from": 11,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "8a8f67da-7a2f-4e30-8e96-4b53af9326bf",
      "evidence": "The thesis headline and propose solution slides present the potential for individualized dosing schedules",
      "position": 1,
      "objective": "Present the potential for individualized dosing schedules",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}